DiaMedica Therapeutics Inc
For the period ended May 22, 2024. Filed Apr 4, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 22, 2024 · Filed Apr 4, 2024
DMAC$9.36+3.5%Stored close · as of Nov 6, 2026
Contents
PROXY STATEMENT SUMMARY
________________
This summary provides an overview of the information included in this proxy statement. We recommend that you review the entire proxy statement and our Annual Report to Shareholders before voting.
2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS
| DATE AND TIME Wednesday, May 22, 2024 9:00 a.m. (CDT) LOCATION DiaMedica Therapeutics Inc. 301 Carlson Parkway, Suite 210, Minneapolis, Minnesota 55305 RECORD DATE Holders of record of our common shares at the close of business on March 25, 2024 are entitled to notice of, to attend, and to vote at the 2024 Annual Meeting. · Voting Item · Board’s Vote Recommendation · Page | ||
|---|---|---|
| Voting Proposal One: Election of Directors | FOR | 11 |
| Voting Proposal Two: Appointment of Independent Registered Public Accounting Firm and Authorization to Fix Remuneration | FOR | 16 |
| Voting Proposal Three: Amendment to DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan | FOR | 18 |
| Voting Proposal Four: Approval, on an Advisory (Non-Binding) Basis, of Executive Compensation | FOR | 31 |
| Voting Proposal Five: Approval, on an Advisory (Non-Binding) Basis, of Frequency of Future Advisory Votes on Executive Compensation | ONE YEAR | 33 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.